Abstract

Trans-active response DNA-binding protein (TDP-43) is a multifunctional regulatory protein, whose abnormal deposition in neurons was linked to debilitating neurodegenerative diseases, such as amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Limbic-predominant age-related TDP-43 encephalopathy, and Alzheimer’s disease with a secondary pathology. Several reports showed that TDP-43 proteinopathy as a comorbidity can form aggregates with other pathological proteins. The co-deposition of alpha synuclein and TDP-43 inclusions was previously reported in glial cells and by observing TDP-43 proteinopathy in Lewy body disease. In this study, it was hypothesized that alpha synuclein and TDP-43 may co-aggregate, resulting in comorbid synucleinopathy and TDP-43 proteinopathy. A solid-phase microplate-based immunoassay was used to map out the epitopes of anti-TDP-43 antibodies and locate the interaction of TDP-43 with α-synuclein. A region of the low complexity domain of TDP-43 (aa 311–314) was shown to interact with full-length α-synuclein. Conversely, full-length TDP-43 was shown to bind to the non-amyloid beta component of α-synuclein. Using in silico sequence-based prediction, the affinity and dissociation constant of full-length TDP-43 and α-synuclein were calculated to be −10.83 kcal/mol and 1.13 × 10−8, respectively. Taken together, this microplate-based method is convenient, economical, and rapid in locating antibody epitopes as well as interaction sites of two proteins.

Highlights

  • Trans-active response DNA-binding protein (43 kDa) (TDP-43) is a regulatory protein linked to various roles in transcriptional repression, mRNA splicing, and regulation of protein translation

  • TDP-43 was reported to co-localize with other protein species characteristic in other neurogenerative diseases, namely Huntington’s disease, Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and Alzheimer’s disease (AD) [7,8,9,10,11]

  • TDP-43 pathology was identified through immunohistochemical analysis in 31% of DLB with AD cases, 7.2% in PD cases, and 19% on PD cases with dementia (PDD), while none were found in DLB and one case in normal controls [8]

Read more

Summary

A Microplate-Based Approach to Map Interactions between TDP-43 and α-Synuclein

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

Introduction
Peptide Synthesis and Preparation
Interaction of α-Synuclein and TDP-43
Full Length TDP-43 Interacts with the NAC Region of α-Synuclein
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call